Overview
Alexandra Pearsall is a skilled corporate attorney with extensive experience advising clients across a wide range of industries on complex legal matters, including commercial contracts, corporate governance, strategic transactions, mergers and acquisitions (M&A), and technology agreements. Alexandra partners with companies from startups to multinational corporations, providing strategic legal counsel to navigate high-stakes transactions and operational challenges. Alexandra’s practice spans drafting, reviewing, and negotiating sophisticated commercial agreements, including licensing, supply, and service agreements tailored to clients’ unique business needs.
In the M&A space, Alexandra has successfully guided clients through mergers, acquisitions, divestitures, and joint ventures, ensuring seamless execution and compliance with regulatory requirements. Alexandra is adept at managing the entire transaction lifecycle, from due diligence to post-closing integration.
Corporate governance is a cornerstone of Alexandra’s practice. Alexandra counsels boards of directors, executives, and shareholders on governance best practices, risk management, and corporate compliance matters. Clients value Alexandra’s ability to translate complex legal concepts into actionable advice that drives informed decision-making.
With a keen interest in the intersection of technology and law, Alexandra has significant experience drafting and negotiating technology agreements, including software licensing, cloud services, and data processing agreements, helping clients protect intellectual property and support their technology-driven initiatives.
Alexandra has extensive experience counseling healthcare and life sciences companies, including pharmaceutical companies, pharmacies, manufacturers and physicians, helping them navigate transactional and regulatory challenges unique to the industry, such as fraud and abuse laws, anti-kickback and self-referral laws, FDA regulations and use and disclosure of health information. Alexandra has substantial experience with industry regulations as it relates to pharmacy benefit manager relationships with pharmacies, manufacturers, wholesalers and plan sponsors.
Alexandra interned at the Office of the Attorney General – Government and Healthcare Fraud Division, conducting investigations related to the False Claims Act in the pharmaceutical industry. In addition, she was also a compliance fellow at a large pharmaceutical company, where she gained experience in policy and risk management by working within the guidance of a corporate integrity agreement.
Experience
No aspect of this advertisement has been approved by the highest court of any state. Prior results do not guarantee a similar outcome.
Defended an independent pharmacy in audit appeal to major pharmacy benefit manager resulting in reversal of over $2 million in recouped funds
Counseled network of physician dispensers regarding network access across various pharmacy benefit managers
Defense of independent pharmacy in State Board of Pharmacy action resulting in avoidance of disciplinary action
Appealed and secured rescission of independent pharmacy network terminations from major pharmacy benefit managers
Education and Credentials
Education
-
Seton Hall University School of Law, J.D., Health Law Outlook, Managing Editor
-
James Madison University, B.A., with Honors
Admissions
- State of New Jersey
Affiliations
- American Bar Association
- American Health Lawyers Association
- American Association for Justice
Recognition and Community
No aspect of this advertisement has been approved by the highest court of any state. Prior results do not guarantee a similar outcome. See Awards Methodology.
Recognitions
Selected to the list of New Jersey Super Lawyers Rising Stars (Thomson Reuters), 2020-2024
News & Insights
Thought Leadership
- Certain ASCs Face New Prior Authorization Payment Requirements from CMS , April 29, 2024
- Generative Artificial Intelligence Representations and Warranties Emerge in Venture Financing Transactions , April 29, 2024
- HHS Issues Long-Awaited Final Rule Modifying Part 2 Regulations , February 28, 2024
- New DOJ Safe Harbor Policy for Voluntary Self-Disclosures in M&A Transactions—What You Should Know , February 28, 2024
- New Providers/Entrants Beware – Ignorance Is Not a Defense , December 20, 2023
In The Media
Publications
- National Publication: A 50 State Survey on Opioid Prescribing Requirements, American Health Lawyers Association (AHLA), November 20, 2019
Speaking Engagements
- PBMs: What Are They & Why They Matter, August 10, 2018
- So a PBM Wants to Terminate Your Contract: The Top 10 Mistakes to Avoid to Keep You in the Network, August 24, 2017